BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20451062)

  • 1. [Report of seven cases of clear-cell meningioma and a literature review].
    Rousselot C; Francois P; Jan M; Bergemer AM
    Ann Pathol; 2010 Apr; 30(2):73-82. PubMed ID: 20451062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic secretory meningioma: a case report.
    Ferchichi L; Bellil S; Ben Hammouda K; Bellil K; Mekni A; Bettaieb I; Haouet S; Khaldi MM; Zitouna K; Kchir N
    Pathologica; 2006 Apr; 98(2):153-5. PubMed ID: 16929789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
    Fornelli A; Bacci A; Collina G; Eusebi V
    Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial clear cell meningioma: a clinicopathologic study of 15 cases.
    Chen H; Li XM; Chen YC; Wu JS; Dou YF; Wang Y; Xu J; Zhong P; Jiang CC; Wang XQ
    Acta Neurochir (Wien); 2011 Sep; 153(9):1769-80. PubMed ID: 21643672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningiomas: immunohistochemical analysis of 26 cases].
    Pérez-Guiones Bacete M; Cerda-Nicolás M; Piquer J; Barcia-Mariño C
    Arch Neurobiol (Madr); 1992; 55(2):43-9. PubMed ID: 1377465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma.
    Zorludemir S; Scheithauer BW; Hirose T; Van Houten C; Miller G; Meyer FB
    Am J Surg Pathol; 1995 May; 19(5):493-505. PubMed ID: 7726360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologically benign intraventricular meningioma with concurrent pulmonary metastasis: case report and review of the literature.
    Fulkerson DH; Horner TG; Hattab EM
    Clin Neurol Neurosurg; 2008 Apr; 110(4):416-9. PubMed ID: 18282656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell meningioma variant and clinical aggressiveness.
    Pimentel J; Fernandes A; Pinto AE; Fonseca I; Moura Nunes JF; Lobo Antunes J
    Clin Neuropathol; 1998; 17(3):141-6. PubMed ID: 9625306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical and pathological features of secretory meningiomas].
    Li XJ; Zhang HY; Lang ZQ; Wei B; Chen HJ; Bu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):488-91. PubMed ID: 16761441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningiomas: correlation of Ki67 with histological grade.
    Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
    Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature.
    Elbabaa SK; Gokden M; Crawford JR; Kesari S; Saad AG
    J Neurosurg Pediatr; 2012 Oct; 10(4):281-90. PubMed ID: 22900483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.